期刊文献+

海洋来源放线菌Actinoalloteichus cyanogriseus WH1-2216-6产浅蓝霉素A的发酵条件优化 被引量:4

Fermentation optimization for the production of caerulomycin A from marine-derived Actinoalloteichus cyanogriseus WH1-2216-6
原文传递
导出
摘要 目的对海洋来源放线菌Actinoalloteichus cyanogriseus WH1-2216-6产浅蓝霉素A的发酵条件进行优化,提高浅蓝霉素A的产量。方法对培养基的组成、接种量、起始pH、盐度、发酵时间、前体浓度及大孔吸附树脂添加量等条件的研究,通过单因素和正交试验,选择最优发酵条件;结果获得了浅蓝霉素A的最佳发酵条件,培养基组成(可溶性淀粉20g,甘油20g,蛋白胨20g,CaCO32g,2-吡啶甲酸400mg,XAD-16大孔吸附树脂50g,陈海水1L)、装液量150/500mL(体积分数)、5d种龄、3.3%盐度、起始pH=7.5、摇床(180r·min-1,28℃)发酵12d。结论以最佳发酵条件发酵,优化后的浅蓝霉素A的产量为优化前的7.0倍,达到610.5mg/L。 Objective To improve the production of caerulomycin A from the marine-derived Actinoalloteichus cyanogriseus WH1-2216-6by the optimization of fermentation conditions.Methods The optimal composition of the medium,inoculum volume,pH,salinity,cultivation time,precursor concentration and addition of resin(XAD-16)were investigated by single-factor experiment and the orthogonal matrix methods.Results The optimal conditions were obtained as following:medium consisted of soluble starch 20 g,glycerol 20 g,peptone 20 g,CaCO32g,picolinic acid 400 mg,XAD-16 macroporous adsorptive resins 50 g,and sea water 1000mL;500mL conical flask containing 150 mL of culture medium;5dold of inoculum age;3.3% of salinity;pH 7.5;and 180 rpm at 28℃for 12 d.Conclusion The highest yield of caerulomycin A,i.e.610.5mg/L,obtained by A.cyanogriseus WH1-2216-6under the optimal fermentation conditions was 7.0-fold high as that in the original condition.
出处 《中国海洋药物》 CAS CSCD 北大核心 2014年第5期9-15,共7页 Chinese Journal of Marine Drugs
基金 国家自然科学基金课题(21172204) 国家重点基础研究发展计划课题(2010CB833804) 国家高技术研究发展计划课题(2013AA092901) 公益性行业科研专项(201405038))资助
关键词 浅蓝霉素A 发酵优化 海洋放线菌 Actinoalloteichus cyanogriseus caerulomycin A fermentation optimization marine-derived actinomycetes Actinoallotei-chus cyanogriseus
  • 相关文献

参考文献13

  • 1朱伟明,王俊锋.海洋真菌生物活性物质研究之管见[J].菌物学报,2011,30(2):218-228. 被引量:45
  • 2郭跃伟.海洋天然产物和海洋药物研究的历史、现状和未来[J].自然杂志,2009,31(1):27-30. 被引量:32
  • 3Blunt J W,Copp B R,Munro MHG.Marine natural prod-ucts[J].NaL Prod.Rep.2011,28(2):196-268.
  • 4Fenical W,Jensen P R.Developing a new resource for drugdiscovery: marine actinomycete bacteria[J].Nat.Chem.BioL 2006,2(12):666-673.
  • 5Fu P,Liu P,Li X,et al.Cyclic bipyridine glycosides fromthe marine-derived actinomycete Actinoalloteichus cyanogri-seus WH1-2216-6[J],Org.Lett.2011,13(22):5948-5951.
  • 6Fu P,Wang S,Hong K,et al.Cytotoxic bipyridines fromthe marine-derived actinomycete Actinoalloteichus cyanogri-seus WH1-2216-6[J],J.Nat.Prod.2011,74(8):17511756.
  • 7Chandran R R,Sankaran R,Divekar P V,Phytotoxic prop-erties of caerulomycin and some of its derivatives[J].J.Antibiol, 1968,21(3):243-243.
  • 8Chatterjee D K,Raether W,Iyer N,et al.Caerulomycin,an antifungal antibiotic with marked in vitro and in vivo ac-tivity against Entamoeba histolytica[J].Z.ParasitenhPar-asitol.Res.1984,70(5):569-573.
  • 9Singla A K,Agrewala J N,Vohra R M,et al.Use of bipyr-idine compound caerulomycin A derivatives and analogsthereof as immunosuppressive agents[P].USA: US 2007/0078167 Al,2007-04-05.
  • 10http://www.fiercebiotech.com/press-releases/nostrum-phar-maceuticals-obtains-worldwide-licensing-rights-imtech-devel-opment-small-m.

二级参考文献55

共引文献76

同被引文献43

  • 1Oxford A E, Raistrick H, Simonart P. Studies in the biochemistry of micro-organisms, griseofulvin C17H17O6C1, a metabolic product of Penicillium griseofulvum Dierckx[J]. Biochem J, 1939, 33(2): 240-248.
  • 2Bumgardner G L, Roberts J P. New immunosuppressive agents[J]. Gastroenterol Clin North Am, 1993, 22(2): 421-449.
  • 3Siegel R L, Miller K D, Jemal A. Cancer statistics, 2015[J]. CA CancerJClin, 2015, 65(1): 5-29.
  • 4Keller N P, Nesbitt C, Sarr B, et al. pH regulation of sterigmatocystin and aflatoxin biosynthesis in Aspergillus spp[J]. Phytopathology, 1997, 87(6): 643-648.
  • 5Fan Y, Wang Y, Liu P P, et al. Indole-diterpenoids with anti-hlnl activity from the aciduric fungus Penicillium camemberti OUCMDZ-1492[J]. J Nat Prod, 2013, 76(7): 1328-1336.
  • 6Stierle D B, Stierle A A, Patacini B. The berkeleyacetals, three meroterpenes from a deep water acid mine waste Penieillium[J]. JNatProd, 2007, 70(11): 1820-1823.
  • 7Wang H, Wang Y, Wang W, et al. Anti-influenza virus polyketides from the acid-tolerant fungus Penicillium purpurogenum JS03-21[J]. J Nat Prod, 2011, 74(9): 2014-2018.
  • 8Wang H, Wang Y, Liu P, et al. Purpurides B and C, two new sesquiterpene esters from the aciduric fungus Penicillium purpurogenum JS03-21[J]. Chern Biodivers, 2013, 10(7): 1185-1192.
  • 9Mosmann T. Rapid eolorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J]. J lmmunol Methods, 1983, 65(1-2): 55-63.
  • 10Kong F, Zhao C, Hao J, et al. New ct-glucosidase inhibitors from a marine sponge-derived fungus, Aspergillus sp. OUCMDZ-1583[J]. RSCAdv, 2015, 5(84): 68852-68863.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部